Saccomano Nicholas A Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$4.04M

Insider Activity of Saccomano Nicholas A

According to the SEC Form 4 filings, Saccomano Nicholas A, being in a position of

  1. President and CEO at OnKure Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 346 shares for $1,252,
    over all time since 2025-04-04, has bought 0 shares, and sold 1396 shares for $4,263.

Biography of Saccomano Nicholas A

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,2524100

Comparison of Insiders on Amount of Buys and Sells

2026-09-21SaleOnKure Therapeutics, Inc.
OKUR
President and CEO
87
0.0002%
$2.97$259-16.99%
2026-06-22SaleOnKure Therapeutics, Inc.
OKUR
President and CEO
86
0.0006%
$4.40$378-14.53%
2026-03-23SaleOnKure Therapeutics, Inc.
OKUR
President and CEO
86
0.0007%
$4.16$357+2.26%
2025-12-22SaleOnKure Therapeutics, Inc.
OKUR
President and CEO
87
0.0007%
$2.97$258+27.7%
2025-09-22SaleOnKure Therapeutics, Inc.
OKUR
President and CEO
88
0.0006%
$2.62$231+29.89%
2025-06-23SaleOnKure Therapeutics, Inc.
OKUR
President and CEO
88
0.0005%
$2.38$210+21.58%
2025-04-07SaleOnKure Therapeutics, Inc.
OKUR
President and CEO
516
0.0035%
$2.67$1,378-11%
2025-04-04SaleOnKure Therapeutics, Inc.
OKUR
President and CEO
358
0.003%
$3.33$1,191-12.14%
2019-02-07SaleArray Technologies, Inc.
ARRY
CSO
187,264
0.3964%
$21.58$4.04M
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.